States move to encourage work for Medicaid; the Trump administration imposes restrictions on immigrants using reciept of government benefits when applying for citizenship; FDA advises against cannabis use for pregnant women.
Pennsylvania health officials devised a gentler approach to getting Medicaid beneficiaries into jobs, amid pressure from its Republican-based legislature to require recipients to work as a condition of coverage, according to Kaiser Health News. Beginning early next year, the Medicaid agency under Democratic Governor Tom Wolf will ask citizens when they enroll if they want job training assistance. This will then require its private Medicaid managed-care organizations to connect those who want help to local employment specialists and follow up to ensure they obtained it. The state, like others trying a similar approach, thinks the strategy will get better results than strict work requirements.
The US Citizenship and Immigration Services announced a new policy change that says immigrants applying for citizenship or other legal status will no longer be able to use receipt of government benefits as a condition to seek a waiver of an application fee, according to The Wall Street Journal. The move comes amid another immigration restriction imposed by the Trump administration that seeks to stop entry or green cards for many legal immigrants who have used Medicaid, food stamps, or housing assistance, or are thought likely to in the future; that action is temporarily blocked by several courts. In addition, the administration is requiring most legal immigrants to demonstrate that they have health insurance.
The FDA strongly advised women not to use cannabis in any form, including CBD, when pregnant or breastfeeding as it may pose serious risks such as premature birth, according to NPR. In the article, women reported using cannabis products to curb issues of food aversion and intense nausea that are synonymous with morning sickness and other pregnancy-related symptoms. However, the FDA points to research showing that THC, the psychoactive component of cannabis, crosses the placenta and can affect fetal brain development, with additional evidence showing its influence on breast milk.
The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in the US
March 26th 2024A presentation at the Greater Philadelphia Business Coalition on Health's 2024 Women’s Health Summit discussed how payers, including employers and public entities, can strategically influence health care purchasing to prioritize maternal health and equity.
Read More
Addressing Maternal Mortality in Medicaid by Focusing on Mental Health
February 15th 2023On this episode of Managed Care Cast, we speak with Inland Empire Health Plan, a managed care plan serving more than 1.4 million residents on Medi-Cal in California, about a new maternal mental health program aimed at supporting new mothers, both before they give birth and afterward.
Listen
For National Women’s Health Week, One Company Emphasizes Cardiovascular Risk Management
May 10th 2022On this episode of Managed Care Cast, we speak with Joanne Armstrong, MD, MPH, vice president and chief medical officer for Women’s Health and Genomics at CVS Health, on the distinct pathophysiology of cardiovascular disease in women and how her own health experiences have influenced her perspective on cardiovascular disease management.
Listen
What We’re Reading: Historic Low of Uninsured; Youth Gender Treatments; Birth Control Recall
August 4th 2023A record low of 7.7% of Americans had no health insurance at the start of 2023; the American Academy of Pediatrics renewed its backing of gender care for children while requesting a research review; 2 lots of an oral contraceptive were recalled for possible reduction in effectiveness.
Read More
Lawyers were questioned in a federal lawsuit intending to overturn approval of a drug used for medication abortion; during the COVID-19 pandemic in 2021, US maternal mortality increased for the third year in a row; the Alzheimer’s Association is lobbying Congress to push for Medicare coverage of new Alzheimer drugs under early access.
Read More